Justin Keywood
Stock Analyst at Stifel Nicolaus
(2.17)
# 3,126
Out of 4,476 analysts
932
Total ratings
51.6%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Justin Keywood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: DHT.UN DRI Healthcare Trust | Maintained: Buy | $23.00 → $24.00 | $19.32 | +24.22% | 44 | Jun 30, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Maintained: Buy | $8.25 | $4.31 | +91.42% | 153 | Jun 15, 2026 | |
| TSX: KSI kneat.com, inc. | Downgraded: Hold | $5.75 → $6.50 | $6.47 | +0.46% | 33 | Jun 10, 2026 | |
| TSX: JWEL Jamieson Wellness Inc. | Maintained: Buy | $45.00 | $41.96 | +7.25% | 48 | Jun 4, 2026 | |
| TSX: ATS ATS Corporation | Maintained: Buy | $52.00 | $39.89 | +30.36% | 134 | May 29, 2026 | |
| NGEN NervGen Pharma | Reiterated: Buy | $6 | $2.12 | +183.02% | 14 | May 21, 2026 | |
| TSX: VHI Vitalhub Corp. | Maintained: Buy | $11.00 | $7.40 | +48.65% | 8 | May 19, 2026 | |
| TSX: CPH Cipher Pharmaceuticals Inc. | Rated: Buy | $21.00 → $22.00 | $17.17 | +28.13% | 38 | May 13, 2026 | |
| TSX: AIDX Healwell AI Inc. | Maintained: Buy | $2.50 | $0.765 | +226.80% | 21 | May 11, 2026 | |
| TSX: GUD Knight Therapeutics Inc. | Maintained: Buy | $7.45 | $9.91 | -24.82% | 53 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.50 | $3.48 | +29.31% | 41 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35.00 | $30.18 | +15.97% | 61 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.50 → $0.58 | $0.65 | -10.77% | 9 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50.00 | $45.19 | +10.64% | 59 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $236.06 | - | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.76 | - | - | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.75 → $4.45 | $4.20 | +5.95% | 102 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.50 | $0.495 | +203.03% | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6.00 → $3.45 | $5.14 | n/a | 47 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.295 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.45 | n/a | 5 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.69 | n/a | 5 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $50.85 | n/a | 8 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.175 | n/a | 5 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.13 | n/a | 6 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $80.06 | n/a | 17 | May 17, 2019 |
DRI Healthcare Trust
Jun 30, 2026
Maintained: Buy
Price Target: $23.00 → $24.00
Current: $19.32
Upside: +24.22%
WELL Health Technologies Corp.
Jun 15, 2026
Maintained: Buy
Price Target: $8.25
Current: $4.31
Upside: +91.42%
kneat.com, inc.
Jun 10, 2026
Downgraded: Hold
Price Target: $5.75 → $6.50
Current: $6.47
Upside: +0.46%
Jamieson Wellness Inc.
Jun 4, 2026
Maintained: Buy
Price Target: $45.00
Current: $41.96
Upside: +7.25%
ATS Corporation
May 29, 2026
Maintained: Buy
Price Target: $52.00
Current: $39.89
Upside: +30.36%
NervGen Pharma
May 21, 2026
Reiterated: Buy
Price Target: $6
Current: $2.12
Upside: +183.02%
Vitalhub Corp.
May 19, 2026
Maintained: Buy
Price Target: $11.00
Current: $7.40
Upside: +48.65%
Cipher Pharmaceuticals Inc.
May 13, 2026
Rated: Buy
Price Target: $21.00 → $22.00
Current: $17.17
Upside: +28.13%
Healwell AI Inc.
May 11, 2026
Maintained: Buy
Price Target: $2.50
Current: $0.765
Upside: +226.80%
Knight Therapeutics Inc.
May 8, 2026
Maintained: Buy
Price Target: $7.45
Current: $9.91
Upside: -24.82%
May 8, 2026
Maintained: Buy
Price Target: $4.50
Current: $3.48
Upside: +29.31%
May 7, 2026
Maintained: Buy
Price Target: $35.00
Current: $30.18
Upside: +15.97%
Mar 27, 2026
Maintained: Buy
Price Target: $0.50 → $0.58
Current: $0.65
Upside: -10.77%
Mar 23, 2026
Maintained: Buy
Price Target: $50.00
Current: $45.19
Upside: +10.64%
Mar 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $236.06
Upside: -
Mar 20, 2026
Maintained: Buy
Price Target: $1.76
Current: -
Upside: -
Mar 13, 2026
Maintained: Hold
Price Target: $4.75 → $4.45
Current: $4.20
Upside: +5.95%
Dec 12, 2025
Initiated Coverage: Buy
Price Target: $1.50
Current: $0.495
Upside: +203.03%
Feb 6, 2025
Downgraded: Hold
Price Target: $6.00 → $3.45
Current: $5.14
Upside: n/a
Apr 28, 2023
Rated: Hold
Price Target: n/a
Current: $0.295
Upside: n/a
Apr 3, 2020
Rated: Hold
Price Target: n/a
Current: $1.45
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $3.69
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $50.85
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $0.175
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $31.13
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $80.06
Upside: n/a